Lyra Therapeutics: Hold Rating Due to Uncertainty in ENLIGHTEN-2 Trial Outcomes

TipRanksNov 14 06:16 ET · Ratings

Express News | Lyra Therapeutics Shares Are Trading Lower After the Company Reported Worse-than-expected Q3 Sales Results

BenzingaNov 13 11:04 ET

BTIG Maintains Lyra Therapeutics(LYRA.US) With Hold Rating

Moomoo NewsNov 13 06:36 ET · Ratings

Lyra Therapeutics | 10-Q: Q3 2024 Earnings Report

SECNov 12 16:30 ET · Announcements

Lyra Therapeutics | 8-K: Lyra Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update

SECNov 12 16:25 ET

Express News | Lyra Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update

ReutersNov 12 16:01 ET